Compounds > ketoconazole
Page last updated: 2024-10-29

ketoconazole and Thoracic Diseases

ketoconazole has been researched along with Thoracic Diseases in 2 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Thoracic Diseases: Disorders affecting the organs of the thorax.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellamy, J1
Milleron, B1
Roger, V1
Roux, P1
Lebreton, C1
Koeger, A1
Dupont, B1
Akoun, G1

Reviews

1 review available for ketoconazole and Thoracic Diseases

ArticleYear
[Semi-invasive aspergillosis with involvement of the thoracic wall cured by itraconazole].
    Revue de pneumologie clinique, 1990, Volume: 46, Issue:4

    Topics: Antifungal Agents; Aspergillosis; Carcinoma, Bronchogenic; Humans; Itraconazole; Ketoconazole; Lung

1990

Other Studies

1 other study available for ketoconazole and Thoracic Diseases

ArticleYear
[Aspergillosis with involvement of the thoracic wall].
    Revue de pneumologie clinique, 1991, Volume: 47, Issue:1

    Topics: Antifungal Agents; Aspergillosis; Humans; Itraconazole; Ketoconazole; Lung Diseases, Fungal; Pneumon

1991